Highlights,Hemogenyx Pharmaceuticals secures funding for phase I trials of its HEMO-CAR-T therapy.,The therapy focuses on ...

Mizuho Securities analyst Salim Syed has maintained their bullish stance on KURA stock, giving a Buy rating today. Salim Syed’s rating ...

The daughter of “FDR Democrats” in New Jersey, she’d worked first as a clinical psychologist. But, after a few years, she found herself drawn to the field of law, “for its political relevance and ...